The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study.

Eduardo Erasmo Mendoza Mireles Erlend Skaga Andres Server Alonso Henning Leske Petter Brandal Eirik Helseth Pål A Rønning Einar Osland Vik-Mo

Published in: Neuro-oncology practice (2023)

We demonstrate an improved survival of GBM patients at the population level associated with an increased fraction of patients with CRCET. The data support the importance of CRCET to improve glioblastoma patient outcomes.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
magnetic resonance
prognostic factors
electronic health record
magnetic resonance imaging
patient reported outcomes
big data
contrast enhanced